MiniMed Fit Payload Wear Pediatric Study

Part of paid clinical trials in Sacramento, California.

Sponsor
Medtronic MiniMed, Inc.
Study ID
NCT07675161
Status
Recruiting

Conditions

  • Diabetes (DM)
  • Diabetes (Insulin-requiring, Type 1 or Type 2)
  • Diabetes in Adolescence
  • Diabetes in Children

Eligibility Criteria

Sex
ALL
Age
7 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • MiniMed Fit Payload adhesive components — DEVICE
    The MiniMed Fit Payload device used in this study will be made of polycarbonate materials, will not contain any electronic or mechanical components, and is intended to mimic the shape and weight of a future product. Each device will consist of the payload assembly and an adhesive patch, which will be adhered to the payload on one side and the subject's skin on the other.

Study Details

The purpose of this study is to assess MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump in participants 7-17 years of age.

Key Dates

First listed
Jun 30, 2026
Start date
Jun 25, 2026
Status verified
Jun 2026
Primary completion
Aug 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: MiniMed Fit Payload adhesive components
    Pediatric participants with insulin-requiring diabetes using the MiniMed Fit Payload adhesive components in different wear locations over a 7-day period.

Primary Outcome Measure

Summary of device survival [ Time Frame: 7 Days ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
Sutter Institute for Medical ResearchSacramentoCalifornia95821-2123
Natalie Marlen
916-570-2756
Gnanagurudasan Prakasam, MD (PRINCIPAL_INVESTIGATOR)
Sansum Diabetes Research InstituteSanta BarbaraCalifornia93105-4321
Fiona Brown
805-682-7640
Andrew Rhinehart, MD (PRINCIPAL_INVESTIGATOR)
Rocky Mountain Clinical ResearchIdaho FallsIdaho83404
Nikki Sharp
(208) 528-9643
David Liljenquist (PRINCIPAL_INVESTIGATOR)
Barry J Reiner MD LLCBaltimoreMaryland21229
Barry Reiner
Barry Reiner (PRINCIPAL_INVESTIGATOR)
Diabetes and Glandular Disease Clinic PASan AntonioTexas78229
Joann Hernandez
210-614-8612
Mark Kipnes (PRINCIPAL_INVESTIGATOR)

Find similar trials in Sacramento, CA

Related Studies